Dermatology · Innovation · AI
Clinical dermatology, powered by artificial intelligence.
Consulting in dermato-oncology, melanoma and market intelligence for the pharmaceutical industry.
A practising dermatologist with the strategic lens the industry needs, and rarely finds.
Still in the clinic
I treat oncodermatology and skin-cancer surgery patients every week. Every recommendation is grounded in what the disease actually does, not in a slide deck.
KOL & advisory
Advisory boards, trial design and launch strategy for international pharma and medtech. A clinician who speaks your language and your customers’.
Evidence-driven
170+ peer-reviewed publications and active trial work. Scientific rigour translated into evidence your teams can stand behind.
Areas of work
-
Clinical Practice
Active dermatologistAn active oncodermatology and skin-surgery practice. It keeps every strategic call honest, and means your data is read by someone who sees the disease daily.
-
Advisory & Strategy
Pharma · Medtech · KOLAdvisory boards, KOL engagement and market-access perspective. Clinical reality translated into strategy the dermatology market actually believes.
-
Clinical Research
Trials & evidenceFrom protocol input to publication. Trial design that anticipates the questions reviewers, regulators and treating clinicians will raise.
-
Digital Health
InnovationDigital dermatology, imaging and decision-support, guided from clinical validation to real-world adoption by the clinicians who will use them.
The evidence behind the advice
Dr. Sebastian Podlipnik, MD, PhD. Dermatologist in dermato-oncology and melanoma at Hospital Clínic de Barcelona, one of Europe’s leading skin-cancer units.
- Doctorate PhD cum laude, Universitat de Barcelona
- Board Medical Tumor Therapy in Dermato-Oncology (2023)
- Board Dermatology & Venereology (2017)
- Research 170+ publications · 44+ high-impact articles
